STOCK TITAN

Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Modular Medical (MODD) signed coverage agreements with the remaining two of the three largest U.S. pharmacy benefit managers for its Pivot insulin pump. The company now has agreements with all three. Their networks collectively cover more than 182 million people and process approximately 80% of U.S. prescription claims.

Individual coverage still depends on the applicable health plan or plan sponsor, including its list of covered products and how it structures benefits. Modular Medical expects the agreements to support Pivot's commercial rollout over the coming year.

Loading...
Loading translation...
2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointTwo new Pivot coverage agreements bring Modular Medical's total to all three of the largest U.S. pharmacy benefit managers.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Commercial rollout is expected by Modular Medical to benefit from the agreements over the coming year.

Negative

  • Minor pointIndividual Pivot coverage still depends on the applicable health plan or plan sponsor's coverage list and benefit design.

Key Figures

PBM agreements: All three Lives covered: More than 182 million U.S. prescription claims: Approximately 80%
PBM agreements
All three
Agreements now cover the nation's three largest PBMs
Lives covered
More than 182 million
Collectively covered by the three PBM networks
U.S. prescription claims
Approximately 80%
Processed by the three PBMs, according to the article

Key Terms

pharmacy benefit managers, formulary
2 terms
pharmacy benefit managers medical
"agreements with the remaining two of the nation's three largest pharmacy benefit managers"
Pharmacy benefit managers are companies that manage prescription drug plans for health insurers, employers, and other organizations. They negotiate prices with drug manufacturers, decide which medications are covered, and handle the distribution of prescriptions. Their role can impact healthcare costs and drug availability, making them an important factor for investors to consider in the healthcare and pharmaceutical industries.
formulary medical
"subject to the formulary decisions and benefit design of the applicable health plan"
A formulary is a list of prescription drugs that a health insurer, hospital system, or government program has approved for coverage and payment. Think of it like an approved menu or shopping list that determines which medicines patients can get with financial help. For investors, formulary placement affects a drug maker’s potential sales, pricing power and market access, so being included—or excluded—can materially change a company’s revenue outlook.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SAN DIEGO, CA / ACCESS Newswire / November 19, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that it has entered into agreements with the remaining two of the nation's three largest pharmacy benefit managers ("PBMs") for its Pivot tubeless patch pump. With these agreements, Modular Medical has now entered into agreements with all three of the nation's largest PBMs, whose networks collectively cover more than 182 million lives and process approximately 80% of U.S. prescription claims.1 Coverage for any individual patient remains subject to the formulary decisions and benefit design of the applicable health plan or plan sponsor.

Drug Channels Institute estimates the top three PBMs consistently process 80% of all equivalent prescription claims2, making comprehensive PBM coverage a critical catalyst for broad commercial distribution.

Modular Medical believes these agreements represent a significant milestone and will support its efforts to drive adoption of Pivot across the U.S. healthcare landscape.

"Securing agreements with all three of the nation's largest PBMs marks a significant milestone in expanding access to Pivot," said Jeb Besser, Chief Executive Officer of Modular Medical. "These contracts establish an important foundation for broader patient access through standard pharmacy benefits and support our commercial rollout over the coming year."

"Access remains one of the most important factors influencing the adoption of insulin pump therapy," added Mark Brady, Director of Managed Markets at Modular Medical. "Securing these agreements supports our core strategy of making Pivot both accessible and affordable, and we believe it will help reduce traditional coverage barriers so more patients can transition from multiple daily injections to advanced pump therapy."

1MMIT Payor Report 2023

2drugchannels.net/2026/03/the-top-pharmacy-benefit-managers-of.html

About Modular Medical

Modular Medical, Inc. (NASDAQ:MODD) is a commercial-stage medical device company focused on the development of innovative insulin delivery technologies designed to simplify diabetes management and increase access to insulin pump therapy. The Company's Pivot™ tubeless patch pump has been developed to provide a user-friendly, flexible, and accessible approach to insulin delivery for people requiring intensive insulin therapy.

About Pivot

The Pivot™ tubeless patch pump is designed to offer a simplified approach to insulin delivery for individuals requiring intensive insulin therapy. Pivot was developed to address barriers that have limited broader adoption of insulin pump therapy among patients currently managing diabetes with multiple daily injections.

For more information, visit www.pivotpump.com.

Forward-Looking Statements

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release, including but not limited to, the anticipated benefits of the agreements with the national PBMs, including providing broader access to the Company's Pivot pump product to individuals with diabetes, the extent to which health plans and plan sponsors adopt formulary coverage for Pivot, the terms, duration and potential termination of the PBM agreements, reimbursement levels and pricing pressure, the timing and success of the Company's commercial launch and rollout of Pivot, the Company's ability to drive broad adoption of Pivot across the U.S. healthcare landscape, the successful development of Modular Medical's proprietary technologies, whether the market will accept Modular Medical's products and services, anticipated consumer demand for the Company's products, whether Modular Medical can successfully manufacture its products at high volumes, the Company's ability to obtain sufficient capital to fund its operations and commercialization, and general economic, industry or political conditions in the United States or internationally, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.

Pivot is a trademark of Modular Medical. All other trademarks mentioned herein are the property of their respective owners.

Company Contact

Jeb Besser, Chief Executive Officer
Modular Medical, Inc.
IR@modular-medical.com

Investor Contact

Valter Pinto, Managing Director
KCSA Strategic Communications
ModularMedical@KCSA.com

SOURCE: Modular Medical, Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many major pharmacy benefit managers have coverage agreements for Modular Medical's Pivot insulin pump?

Modular Medical now has Pivot agreements with all three of the largest U.S. pharmacy benefit managers. Their networks collectively cover more than 182 million people and process approximately 80% of U.S. prescription claims.

Do Modular Medical's Pivot agreements guarantee coverage for individual patients?

No. Individual coverage remains subject to the applicable health plan or plan sponsor's decisions about which products it covers and how it structures benefits.

Keep reading